Pentadecapeptide (BPC-157 Arginate)

Research Phase
Recovery & Healing
Pentadecapeptide (BPC-157 Arginate)

An enhanced oral-stable form of BPC-157 combined with arginine salt for improved bioavailability and systemic healing effects.

Administration

Oral capsule

Dosage Range

500 mcg twice daily

Mechanism of Action

BPC-157 Arginate combines the tissue-healing properties of BPC-157 with improved oral stability through arginine salt formation. It maintains all healing pathways while offering better absorption through the GI tract.

Clinical Benefits

Enhanced oral bioavailability
Systemic healing effects
Gut-brain axis support
Improved stability over standard BPC-157
Convenient oral administration

Clinical Evidence

Building on BPC-157's extensive preclinical database, the arginate form shows improved oral bioavailability in preliminary studies. Clinical trials are in early stages for oral administration efficacy.

Side Effects

Mild GI discomfort
Nausea (rare)
Headache (rare)

Contraindications

Active cancer
Pregnancy
Children under 18

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Peptide therapy should only be administered under the supervision of a qualified healthcare provider. Always consult your physician before starting any new treatment protocol.